The Inflammatory State of Psoriasis: New and Emerging Therapies
WebcastFaculty
OVERVIEW
The Inflammatory State of Psoriasis: New and Emerging Therapies is organized by National Association for Continuing Education (NACE) and will be held during Feb 14, 2017 - Feb 13, 2018.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This monograph reviews the presentation, evaluation, and management of psoriasis – and its many comorbidities – with a focus on the role of primary care clinicians.
Psoriasis is a common and debilitating disease that initially presents to primary care. Many clinicians are familiar with the typical dermatologic lesions of psoriasis, but may not realize that the impact of the disease extend far deeper than the skin. The inflammatory state underlying psoriasis likely contributes to increased risk for multiple serious comorbidities, including psoriatic arthritis, metabolic syndrome, cardiovascular disease, and lymphoma, among others. Patients with psoriasis report significant deficits in their quality of life, including their ability to work and engage in social relationships, Worse yet, psoriasis is associated with increased risk for mortality.
Conference Objectives are:
• Recognize the clinical presentation and current immunopathophysiology of psoriasis and psoriatic arthritis.
• Identify and discuss the significance of the ever-expanding numbers of co-morbid conditions and emerging biofactors associated with psoriatic disease.
• Discuss current therapeutic protocols for psoriasis and its related disorders .
• Interpret latest evidence-based data on emerging treatment options for psoriatic disease.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This monograph reviews the presentation, evaluation, and management of psoriasis – and its many comorbidities – with a focus on the role of primary care clinicians.
Psoriasis is a common and debilitating disease that initially presents to primary care. Many clinicians are familiar with the typical dermatologic lesions of psoriasis, but may not realize that the impact of the disease extend far deeper than the skin. The inflammatory state underlying psoriasis likely contributes to increased risk for multiple serious comorbidities, including psoriatic arthritis, metabolic syndrome, cardiovascular disease, and lymphoma, among others. Patients with psoriasis report significant deficits in their quality of life, including their ability to work and engage in social relationships, Worse yet, psoriasis is associated with increased risk for mortality.
Conference Objectives are:
• Recognize the clinical presentation and current immunopathophysiology of psoriasis and psoriatic arthritis.
• Identify and discuss the significance of the ever-expanding numbers of co-morbid conditions and emerging biofactors associated with psoriatic disease.
• Discuss current therapeutic protocols for psoriasis and its related disorders .
• Interpret latest evidence-based data on emerging treatment options for psoriatic disease.
Additional details will be posted as soon as they are available.
SPECIALITIES
DermatologyRELATED ONLINE COURSES
Quick Links